Particularly noteworthy, Duethorn et al. observed that EPLIN depletion in pluripotent cells exacerbates blebbing [17], suggesting that in pathological conditions like cancer, this phenomenon may amplify tumor resistance to protease inhibitors. The gene discussed is LIMA1; the disease is neoplasm.